TG Therapeutics (TGTX) Stock
TG Therapeutics (TGTX) closed at $64.51 on Nov 13, 2026; its Tenet Score is 45 of 100 against 409 Healthcare peers.
9 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Previous close
- $64.51
- Nov 13, 2026
- Market cap
- $9.9B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- P/E
- 23.0×
- price ÷ earnings
- 52-week range
- 26.76 – 68.03
- low → high
- Tenet Score
- 45/100
- Mixed · 409 Healthcare peers
Industry: Drugs · see every company filed here →
TG Therapeutics Inc scores 45/100. Mixed. Strongest on quality, value is the soft spot, trading at 23× earnings versus 409 Healthcare peers. Insufficient inputs: Tenet 45 is built from 3 of 4 pillars, from 90% of its inputs. Growth is left out because no growth rate could be measured.
Tenet Score · vs sector
n=409Factor grades
Growth omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ~ Buffett Quality
- ✕ Piotroski F-Score
- ~ Munger Compounders
- ✕ Magic Formula
- ✕ Graham Defensive
- ✕ Quality Compounder
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab,…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Halozyme Therapeutics Inc.HALO | 68 | $11.4B |
| Summit Therapeutics IncSMMT | 27 | $11.3B |
| Biomarin Pharmaceutical Inc.BMRN | 51 | $11.1B |
| Kymera Therapeutics IncKYMR | 44 | $10.9B |
| Repligen Corp.RGEN | 47 | $10.7B |
| Madrigal Pharmaceuticals IncMDGL | 32 | $9.9B |
| Spyre Therapeutics Inc.SYRE | 44 | $9.9B |
| Praxis Precision Medicines IncPRAX | 46 | $9.2B |
| Krystal Biotech IncKRYS | 65 | $9.0B |
| Protagonist Therapeutics IncPTGX | 62 | $8.5B |
Common questions
What sector and industry is TG Therapeutics in?
TG Therapeutics is in the Healthcare sector and the Drugs industry.
What is TG Therapeutics' Tenet Score?
TG Therapeutics' Tenet Score is 45 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.




